Louanne W Davis1, Arlene A Schmid2, Joanne K Daggy3, Ziyi Yang3, Caitlin E O'Connor4, Nancy Schalk5, Ai-Nghia L Do4, Danka Maric6, Donna Lazarick7, Heidi Knock7. 1. Department of Research, Roudebush Veterans Affairs Medical Center. 2. Department of Occupational Therapy, Colorado State University. 3. Department of Biostatistics, Indiana University School of Medicine. 4. Veterans Affairs Health Services Research and Development Service Center for Health Information and Communication, Roudebush Veterans Affairs Medical Center. 5. Heartland Yoga Therapy. 6. Department of Psychological Science, Ball State University. 7. Department of Psychiatry, Roudebush Veterans Affairs Medical Center.
Abstract
OBJECTIVE: Although yoga shows promise as a treatment for posttraumatic stress disorder (PTSD), there are few randomized controlled trials that demonstrate significant benefits for individuals with PTSD. The present study addresses this need by comparing the effects of a holistic yoga program (HYP) to that of a wellness lifestyle program (WLP) on PTSD symptom severity with a randomized clinical trial. METHOD: The sample consisted of 209 participants (91.4% veterans; 66% male; 61.7% White) who met diagnostic criteria for PTSD at baseline. Participants were randomly assigned to attend one of the 2 weekly interventions for 16 weeks. The HYP consisted of yoga instruction, while the WLP consisted of didactics, discussions, and walking. PTSD severity was measured using the Clinician Administered PTSD Scale (CAPS-5) and the PTSD Checklist (PCL-5). RESULTS: Analyses revealed that the HYP reduced PTSD severity measured by the CAPS-5 significantly more than the WLP at treatment end (mean difference = -5.4, effect size = 0.46, p < .001), but not at 7-month follow up (mean difference = -0.9, p = .603). Similarly, the HYP reduced PTSD severity measured by the PCL-5 significantly more than the WLP at treatment end (difference = -6.0, p = .001), but not at 7-month follow up (mean difference = -1.0, p = .682). CONCLUSION: Yoga may be an effective intervention for PTSD in addition to standard treatments. Future yoga trials should consider adding a social component to interventions or booster classes to maintain effects long term. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
RCT Entities:
OBJECTIVE: Although yoga shows promise as a treatment for posttraumatic stress disorder (PTSD), there are few randomized controlled trials that demonstrate significant benefits for individuals with PTSD. The present study addresses this need by comparing the effects of a holistic yoga program (HYP) to that of a wellness lifestyle program (WLP) on PTSD symptom severity with a randomized clinical trial. METHOD: The sample consisted of 209 participants (91.4% veterans; 66% male; 61.7% White) who met diagnostic criteria for PTSD at baseline. Participants were randomly assigned to attend one of the 2 weekly interventions for 16 weeks. The HYP consisted of yoga instruction, while the WLP consisted of didactics, discussions, and walking. PTSD severity was measured using the Clinician Administered PTSD Scale (CAPS-5) and the PTSD Checklist (PCL-5). RESULTS: Analyses revealed that the HYP reduced PTSD severity measured by the CAPS-5 significantly more than the WLP at treatment end (mean difference = -5.4, effect size = 0.46, p < .001), but not at 7-month follow up (mean difference = -0.9, p = .603). Similarly, the HYP reduced PTSD severity measured by the PCL-5 significantly more than the WLP at treatment end (difference = -6.0, p = .001), but not at 7-month follow up (mean difference = -1.0, p = .682). CONCLUSION: Yoga may be an effective intervention for PTSD in addition to standard treatments. Future yoga trials should consider adding a social component to interventions or booster classes to maintain effects long term. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
Authors: Elizabeth J Auguste; Rachel E Weiskittle; Stephanie J Sohl; Suzanne C Danhauer; Kelly Doherty; Aanand D Naik; Jennifer Moye Journal: Fed Pract Date: 2021-10
Authors: Tosca D Braun; Lisa A Uebelacker; Mariana Ward; Cathryn Glanton Holzhauer; Kelly McCallister; Ana Abrantes Journal: Complement Ther Med Date: 2021-05-06 Impact factor: 2.446
Authors: Ariel J Lang; Anne Malaktaris; Katrina S Maluf; Julie Kangas; Selin Sindel; Matthew Herbert; Jessica Bomyea; Alan N Simmons; Judy Weaver; Deborah Velez; Lin Liu Journal: Contemp Clin Trials Commun Date: 2021-01-28
Authors: Arlene A Schmid; Elizabeth A Sternke; Ai-Nghia L Do; Nancy Schalk Conner; Vincent R Starnino; Louanne W Davis Journal: Int J Yoga Date: 2021-05-10